Intec Pharma (NTEC) BidaskScore is upgraded to Sold

Intec Pharma

The BidaskScore of Intec Pharma NTECNTEC shows that the shares of the company are now NTECStrongly Bought Sold by investors.

The BidaskScore of the BiotechnologyBiotechnology shows that the sector is BiotechnologyStrongly Bought Strongly Sold since October 22.

Here are the BidAskScore of other related companies in the Biotechnology sector:

Intec Pharma Ltd. is a clinical-stage biopharmaceutical companyˌ which focuses on developing drugs based on its proprietary Accordion Pill platform technology. Its product pipeline includes four product candidates in clinical trial stages: Accordion Pill Carbidopa/Levodopaˌ which is being developed for the treatment of Parkinsonʿs disease symptoms in advanced Parkinsonʿs disease patients; Accordion Pill Zaleplonˌ which is being developed for the treatment of insomniaˌ including sleep induction and the improvement of sleep maintenance; an Accordion Pill that is being developed for the prevention and treatment of gastroduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug which induces ulcers; and AP-CBD/THCˌ an Accordion Pill with the two primary cannabinoids contained in Cannabis sativaˌ cannabidiol and tetrahydrocannabinolˌ which is being developed … read more

Intec Pharma

Launched in 2016, the BidAskClubBidaskClub allows users to follow the evolution of the US equity market. BidaskClub provides a platform to create portfolios and be informed when a company´s or sector’s BidaskScore changes. BidaskClub is provided by LuxFinAdviceLuxFinAdvice.